2.68 USD
0 (0%)
2.7 USD
+0.02 (+0.75%)
Taking everything into account, GDRX scores 6 out of 10 in our fundamental rating. GDRX was compared to 35 industry peers in the Health Care Technology industry. GDRX has only an average score on both its financial health and profitability. GDRX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, GDRX could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
- In the past year GDRX was profitable.
- GDRX had a positive operating cash flow in the past year.
- In the past 5 years GDRX reported 4 times negative net income.
- In the past 5 years GDRX always reported a positive cash flow from operatings.
1.2 Ratios
- GDRX's Return On Assets of 2.40% is amongst the best of the industry. GDRX outperforms 85.71% of its industry peers.
- With an excellent Return On Equity value of 5.29%, GDRX belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 5.73%, GDRX belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROIC | 5.73% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- GDRX has a better Profit Margin (3.97%) than 88.57% of its industry peers.
- In the last couple of years the Profit Margin of GDRX has declined.
- GDRX's Operating Margin of 10.37% is amongst the best of the industry. GDRX outperforms 85.71% of its industry peers.
- GDRX's Operating Margin has declined in the last couple of years.
- GDRX has a better Gross Margin (93.46%) than 100.00% of its industry peers.
- GDRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GDRX is destroying value.
- The number of shares outstanding for GDRX has been reduced compared to 1 year ago.
- GDRX has about the same amout of shares outstanding than it did 5 years ago.
- Compared to 1 year ago, GDRX has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.42, we must say that GDRX is in the distress zone and has some risk of bankruptcy.
- GDRX has a Altman-Z score (0.42) which is in line with its industry peers.
- GDRX has a debt to FCF ratio of 4.66. This is a neutral value as GDRX would need 4.66 years to pay back of all of its debts.
- GDRX's Debt to FCF ratio of 4.66 is in line compared to the rest of the industry. GDRX outperforms 60.00% of its industry peers.
- GDRX has a Debt/Equity ratio of 0.81. This is a neutral value indicating GDRX is somewhat dependend on debt financing.
- GDRX has a worse Debt to Equity ratio (0.81) than 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Altman-Z | 0.42 |
ROIC/WACC0.54
WACC10.57%
2.3 Liquidity
- A Current Ratio of 3.11 indicates that GDRX has no problem at all paying its short term obligations.
- The Current ratio of GDRX (3.11) is better than 62.86% of its industry peers.
- GDRX has a Quick Ratio of 3.11. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 3.11, GDRX is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 9.37% over the past year.
- Measured over the past years, GDRX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.47% on average per year.
- The Revenue has been growing slightly by 1.30% in the past year.
- GDRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.34% yearly.
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
3.2 Future
- The Earnings Per Share is expected to grow by 25.32% on average over the next years. This is a very strong growth
- GDRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.00% yearly.
EPS Next Y11.45%
EPS Next 2Y15.72%
EPS Next 3Y16.53%
EPS Next 5Y25.32%
Revenue Next Year0.14%
Revenue Next 2Y1.37%
Revenue Next 3Y3.29%
Revenue Next 5Y5%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- GDRX is valuated cheaply with a Price/Earnings ratio of 7.66.
- Compared to the rest of the industry, the Price/Earnings ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 100.00% of the companies listed in the same industry.
- GDRX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.38.
- GDRX is valuated cheaply with a Price/Forward Earnings ratio of 6.06.
- 100.00% of the companies in the same industry are more expensive than GDRX, based on the Price/Forward Earnings ratio.
- GDRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.29, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.66 | ||
| Fwd PE | 6.06 |
4.2 Price Multiples
- GDRX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GDRX is cheaper than 94.29% of the companies in the same industry.
- 91.43% of the companies in the same industry are more expensive than GDRX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.67 | ||
| EV/EBITDA | 6.85 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of GDRX may justify a higher PE ratio.
- A more expensive valuation may be justified as GDRX's earnings are expected to grow with 16.53% in the coming years.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y15.72%
EPS Next 3Y16.53%
5. Dividend
5.1 Amount
- No dividends for GDRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
2.68
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners50.75%
Inst Owner Change0.09%
Ins Owners11.19%
Ins Owner Change10.68%
Market Cap909.67M
Revenue(TTM)800.65M
Net Income(TTM)31.75M
Analysts74.29
Price Target4.83 (80.22%)
Short Float %8.84%
Short Ratio3.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.02%
Min EPS beat(2)-13.38%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.95%
Min EPS beat(4)-13.38%
Max EPS beat(4)-7.12%
EPS beat(8)2
Avg EPS beat(8)-4.79%
EPS beat(12)6
Avg EPS beat(12)4.06%
EPS beat(16)9
Avg EPS beat(16)11.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.22%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.22%
Revenue beat(8)0
Avg Revenue beat(8)-1.92%
Revenue beat(12)1
Avg Revenue beat(12)-1.83%
Revenue beat(16)2
Avg Revenue beat(16)-1.59%
PT rev (1m)-6.88%
PT rev (3m)-10.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.06%
EPS NY rev (1m)0.19%
EPS NY rev (3m)-3.54%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.66 | ||
| Fwd PE | 6.06 | ||
| P/S | 1.14 | ||
| P/FCF | 8.67 | ||
| P/OCF | 5.06 | ||
| P/B | 1.51 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.85 |
EPS(TTM)0.35
EY13.06%
EPS(NY)0.44
Fwd EY16.49%
FCF(TTM)0.31
FCFY11.53%
OCF(TTM)0.53
OCFY19.76%
SpS2.36
BVpS1.77
TBVpS-0.08
PEG (NY)0.67
PEG (5Y)N/A
Graham Number3.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROCE | 7.26% | ||
| ROIC | 5.73% | ||
| ROICexc | 7.53% | ||
| ROICexgc | 26.92% | ||
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% | ||
| FCFM | 13.11% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y37.95%
ROICexgc growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score6
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Debt/EBITDA | 2.95 | ||
| Cap/Depr | 92.2% | ||
| Cap/Sales | 9.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 109.5% | ||
| Profit Quality | 330.43% | ||
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 | ||
| Altman-Z | 0.42 |
F-Score6
WACC10.57%
ROIC/WACC0.54
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
EPS Next Y11.45%
EPS Next 2Y15.72%
EPS Next 3Y16.53%
EPS Next 5Y25.32%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
Revenue Next Year0.14%
Revenue Next 2Y1.37%
Revenue Next 3Y3.29%
Revenue Next 5Y5%
EBIT growth 1Y179.68%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year34.43%
EBIT Next 3Y15.99%
EBIT Next 5Y13.87%
FCF growth 1Y9.18%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y16.5%
OCF growth 3Y0.94%
OCF growth 5Y17.16%
GOODRX HOLDINGS INC-CLASS A / GDRX FAQ
Can you provide the ChartMill fundamental rating for GOODRX HOLDINGS INC-CLASS A?
ChartMill assigns a fundamental rating of 6 / 10 to GDRX.
What is the valuation status for GDRX stock?
ChartMill assigns a valuation rating of 9 / 10 to GOODRX HOLDINGS INC-CLASS A (GDRX). This can be considered as Undervalued.
What is the profitability of GDRX stock?
GOODRX HOLDINGS INC-CLASS A (GDRX) has a profitability rating of 6 / 10.
What is the earnings growth outlook for GOODRX HOLDINGS INC-CLASS A?
The Earnings per Share (EPS) of GOODRX HOLDINGS INC-CLASS A (GDRX) is expected to grow by 11.45% in the next year.